New deal allows generics makers license to sell HIV drug

With a new licensing agreement, makers of generic drugs can now develop and sell a pediatric HIV drug to low- and middle-income countries. We reached out to the Medicines Patent Pool to give you the inside track into what this deal means for the global HIV and AIDS fight.

About the author

  • Jenny Lei Ravelo

    Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.